Impact of a pertussis booster vaccination program in adolescents and adults on the epidemiology of pertussis in Austria

Pediatric Infectious Disease Journal

Volumn 26, Issue 9, 2007, Pages 806-810

  Rendi Wagner, Pamela ^a   Paulke Korinek, Maria ^a   Stanek, Gerold ^a   Khanakah, Gelas ^a   Kollaritsch, Herwig ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adolescents; Adults; Epidemiology; Pertussis; Vaccination

Indexed keywords

PERTUSSIS VACCINE;

ADOLESCENT; ADULT; ARTICLE; AUSTRIA; BORDETELLA PERTUSSIS; CLINICAL TRIAL; CONTROLLED STUDY; EUROPE; GENE SEQUENCE; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL VARIATION; SEQUENCE ANALYSIS; SERODIAGNOSIS; VACCINATION;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRIA; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNIZATION SCHEDULE; INCIDENCE; INFANT; MIDDLE AGED; PERTUSSIS VACCINE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; SENTINEL SURVEILLANCE; WHOOPING COUGH;

EID: 34548273199     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e318124a9dd     Document Type: Article

References (25)

1. WHO. Laboratory Manual for the Diagnosis of Whooping Cough Caused by Bordetella pertussis/Bordetella parapertussis. Geneva, Switzerland: Department of Immunization, Vaccines and Biologicals; 2004. WHO/IVB/04.14.
2. Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J. 2005;24(5 suppl):S25-S34.
3. Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B. Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis. 2001;32:1691-1697.
4. Hewlett EL, Edwards KM. Clinical practice. Pertussis - not just for kids. N Eng J Med. 2005;352:1215-1222.
5. Schafer S, Gillette H, Hedberg K, Cieslak P. A community-wide pertussis outbreak: an argument for universal booster vaccination. Arch Intern Med. 2006;166:1317-1321.
6. Gzyl A, Augustynowicz E, Rabczenko D, Gniadek G, Slusarczyk J. Pertussis in Poland. Int J Epidemiol. 2004;33:358-365.
7. Güris D, Strebel PM, Bardenheier B, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999;28:1230-1237.
8. Yih WK, Lett SM, des Vignes FN, Garrison KM, Sipe PL, Marchant CD. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998. J Infect Dis. 2000;182:1409-1416.
9. Tanaka M, Vitek CR, Pascual FB, Bisgard KM, Tate JE, Murphy TV. Trends in pertussis among infants in the United States, 1980-1999. JAMA. 2003;290:2968-2975.
10. Moerman L, Leventhal A, Slater PE, Anis E, Yishai R, Marva E. The re-emergence of pertussis in Israel. Isr Med Assoc J. 2006;8:308-311.
11. Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185:1448-1453.
12. Ntezayabo B, De Serres G, Duval B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J. 2003;22:22-27.
13. McIntyre P, Gidding H, Gilmour R, et al. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. Vaccine preventable diseases and vaccination coverage in Australia, 1999-2000. Commun Dis Intell. 2002;26(suppl):1-11.
14. Rendi-Wagner P, Kundi M, Mikolasek A, Vecsei A, Fruhwirth M, Kollaritsch H. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine. 2006;24:5960-5965.
15. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326-382.
16. Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984;14:1-78.
17. Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J. 2005;24(5 suppl):S93-S97.
18. Wirsing von Konig CH, Campins-Marti M, Finn A, Guiso N, Mertsola J, Liese J. Pertussis immunization in the global pertussis initiative European region: recommended strategies and implementation considerations. Pediatr Infect Dis J. 2005;24(5 suppl):S87-S92.
19. Tan T, Halperin S, Cherry JD, et al. Pertussis immunization in the global pertussis initiative North American region: recommended strategies and implementation considerations. Pediatr Infect Dis J. 2005;24(5 suppl):S83-S86.
20. Statistik Austria, Population Statistics (341). Available at: ftp://www.statistik.at/pub/neuerscheinungen/2005/demographjb2004_www.pdf and http://www.statistik.at/fachbereich_03/bevoelkerung_tab2. shtml. Accessed December 1, 2006.
21. Boursaux-Eude C, Thiberge S, Carletti G, Guiso N. Intranasal murine model of Bordetella pertussis infection. II. Sequence variation and protection induced by a tricomponent acellular vaccine. Vaccine. 1999;17:2651-2660.
22. Tozzi AE; EUVAC-NET Group. Celentano LP, Massari M, Paramatti D, Salmaso S, Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24:761-765.
23. Gregory DS. Pertussis: a disease affecting all ages. Am Fam Physician. 2006;74:420-426.
24. Meade BD, Bollen A. Recommendations for use of the polymerase chain reaction in the diagnosis of Bordetella pertussis infections. J Med Microbiol. 1994;41:51-55.
25. Bundesministerium für Gesundheit und Frauen. Monats- und Jahresausweise über angezeigte übertragbare Krankheiten. Available at: http://www.bmgf.gv.at/cms/site/detail.htm?thema=CH0019&doc= CMS1038913958779. Accessed November 23, 2006.